Spravato (Esketamine)
Spravato or esketamine is a form of ketamine, used to treat adults with treatment-resistant depression (TRD). Unlike traditional antidepressants that target neurotransmitters like serotonin or norepinephrine and take weeks to show effects, Spravato leads to rapid changes in brain connectivity, resulting in some patients seeing an improvement in mood within hours or days.
Why Spravato?
Here at Joyful Horizon, we offer a wide variety of different treatments for depression, but let us share a few reasons why you may want to consider Spravato treatment…
Spravato is now fully FDA approved as a monotherapy treatment for Major Depressive Disorder
Clinical trials suggest that Spravato is more effective in treating depressive symptoms as compared to typical antidepressants
Some patients saw a significant improvement in depressive symptoms within just hours of their first session
Spravato has far fewer side-effects as compared to typical antidepressants